$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Dose-dependent and strain-dependent anti-obesity effects of Lactobacillus sakei in a diet induced obese murine model 원문보기

PeerJ, v.7, 2019년, pp.e6651 -   

Ji, Yosep (Department of Advanced Green Energy and Environment, Handong Global University , Pohang, Gyungbuk , South Korea) ,  Chung, Young Mee (Beneficial Microbes Center, CJ Foods R&D, CJ CheilJedang Corporation , Suwon, Gyeonggi , South Korea) ,  Park, Soyoung (Department of Advanced Green Energy and Environment, Handong Global University , Pohang, Gyungbuk , South Korea) ,  Jeong, Dahye (Beneficial Microbes Center, CJ Foods R&D, CJ CheilJedang Corporation , Suwon, Gyeonggi , South Korea) ,  Kim, Bongjoon (Beneficial Microbes Center, CJ Foods R&D, CJ CheilJedang Corporation , Suwon, Gyeonggi , South Korea) ,  Holzapfel, Wilhelm Heinrich (Department of Advanced Green Energy and Environment, Handong Global University , Pohang, Gyungbuk , South Korea)

Abstract AI-Helper 아이콘AI-Helper

BackgroundOverweight and abdominal obesity, in addition to medical conditions such as high blood pressure, high blood sugar and triglyceride levels, are typical risk factors associated with metabolic syndrome. Yet, considering the complexity of factors and underlying mechanisms leading to these infl...

주제어

참고문헌 (81)

  1. Ahmadi, Alizadeh-Navaei & Rezai (2015) Ahmadi E Alizadeh-Navaei R Rezai MS Efficacy of probiotic use in acute rotavirus diarrhea in children: a systematic review and meta-analysis Caspian Journal of Internal Medicine 2015 6 4 187 195 26644891 

  2. Alard et al. (2016) Alard J Lehrter V Rhimi M Mangin I Peucelle V Abraham AL Mariadassou M Maguin E Waligora-Dupriet AJ Pot B Wolowczuk I Grangette C Beneficial metabolic effects of selected probiotics on diet-induced obesity and insulin resistance in mice are associated with improvement of dysbiotic gut microbiota Environmental Microbiology 2016 18 5 1484 1497 10.1111/1462-2920.13181 26689997 

  3. Alemka et al. (2010) Alemka A Clyne M Shanahan F Tompkins T Corcionivoschi N Bourke B Probiotic colonization of the adherent mucus layer of HT29MTXE12 cells attenuates Campylobacter jejuni virulence properties Infection and Immunity 2010 78 6 2812 2822 10.1128/IAI.01249-09 20308300 

  4. Aller et al. (2011) Aller R De Luis DA Izaola O Conde R Gonzalez Sagrado M Primo D De La Fuente B Gonzalez J Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial European Review for Medical and Pharmacological Sciences 2011 15 1090 1095 22013734 

  5. Al-muzafar & Amin (2017) Al-muzafar HM Amin KA Probiotic mixture improves fatty liver disease by virtue of its action on lipid profiles, leptin, and inflammatory biomarkers BMC Complementary and Alternative Medicine 2017 17 1 43 10.1186/s12906-016-1540-z 28086768 

  6. Amar et al. (2011) Amar J Chabo C Waget A Klopp P Vachoux C Bermudez-Humaran LG Smirnova N Berge M Sulpice T Lahtinen S Ouwehand A Langella P Rautonen N Sansonetti P Burcelin R Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment EMBO Molecular Medicine 2011 3 9 559 572 10.1002/emmm.201100159 21735552 

  7. Armougom et al. (2009) Armougom F Henry M Vialettes B Raccah D Raoult D Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and Methanogens in anorexic patients PLOS ONE 2009 4 9 e7125 10.1371/journal.pone.0007125 19774074 

  8. Aulbach & Amuzie (2017) Aulbach AD Amuzie CJ Faqi AS Biomarkers in nonclinical drug development. Chapter 17 A Comprehensive Guide to Toxicology in Nonclinical Drug Development 2017 Second Edition London Academic Press (Elsevier) 447 471 

  9. Borgeraas et al. (2017) Borgeraas H Johnson LK Skattebu J Hertel JK Hjelmesæth J Effects of probiotics on body weight, body mass index, fat mass and fat percentage in subjects with overweight or obesity: a systematic review and meta-analysis of randomized controlled trials Obesity Reviews 2017 19 2 219 232 10.1111/obr.12626 29047207 

  10. Boulange et al. (2016) Boulange CL Neves AL Chilloux J Nicholson JK Dumas M-E Impact of the gut microbiota on inflammation, obesity, and metabolic disease Genome Medicine 2016 8 1 42 10.1186/s13073-016-0303-2 27098727 

  11. Bron et al. (2017) Bron PA Kleerebezem M Brummer R-J Cani PD Mercenier A MacDonald TT Garcia-Ródenas CL Wells JM Can probiotics modulate human disease by impacting intestinal barrier function? British Journal of Nutrition 2017 117 1 93 107 10.1017/S0007114516004037 28102115 

  12. Bubnov et al. (2017) Bubnov RV Babenko LV Lazarenko LM Mokrozub VV Demchenko OA Nechypurenko OV Spivak MY Comparative study of probiotic effects of Lactobacillus and Bifidobacteria strains on cholesterol levels, liver morphology and the gut microbiota in obese mice EPMA Journal 2017 8 4 357 376 10.1007/s13167-017-0117-3 29209439 

  13. Bubnov et al. (2018) Bubnov RV Babenko LV Lazarenko LM Mokrozub VV Spivak MY Specific properties of probiotic strains: relevance and benefits for the host EPMA Journal 2018 9 2 205 223 10.1007/s13167-018-0132-z 29896319 

  14. Buettner, Schölmerich & Bollheimer (2007) Buettner R Schölmerich J Bollheimer LC High-fat diets: modeling the metabolic disorders of human obesity in rodents Obesity 2007 15 4 798 808 10.1038/oby.2007.608 17426312 

  15. Buss et al. (2014) Buss C Valle-Tovo C Miozzo S Alves de Mattos A Probitoics and synbiotics may improve aminotransferases levels in non-alcoholic fatty liver disease patients Annals of Hepatology 2014 13 5 482 488 25152979 

  16. Cani & Delzenne (2009) Cani PD Delzenne NM Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota Current Opinion in Pharmacology 2009 9 6 737 743 10.1016/j.coph.2009.06.016 19628432 

  17. Chandler et al. (2017) Chandler M Cunningham S Lund EM Khanna C Naramore R Patel A Day MJ Obesity and associated comorbidities in people and companion animals: a one health perspective Journal of Comparative Pathology 2017 156 4 296 309 10.1016/j.jcpa.2017.03.006 28460795 

  18. Chattophadyay & Mathili (2018) Chattophadyay A Mathili S The journey of gut microbiome—an introduction and its influence on metabolic disorders Frontiers in Biology 2018 13 5 327 341 10.1007/s11515-018-1490-6 

  19. Chen et al. (2015) Chen L Zou Y Peng J Lu F Yin Y Li F Yang J Lactobacillus acidophilus suppresses colitis-associated activation of the IL-23/Th17 axis Journal of Immunology Research 2015 2015 1 10 10.1155/2015/909514 

  20. Chung et al. (2016) Chung H-J Yu JG Lee I-A Liu M-J Shen Y-F Sharma SP Jamal MAHM Yoo J-H Kim H-J Hong S-T Intestinal removal of free fatty acids from hosts by Lactobacillifor the treatment of obesity FEBS Open Bio 2016 6 1 64 76 10.1002/2211-5463.12024 

  21. Collins et al. (2004) Collins S Martin TL Surwit RS Robidoux J Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: physiological and molecular characteristics Physiology & Behavior 2004 81 2 243 248 10.1016/j.physbeh.2004.02.006 15159170 

  22. Collins, Thornton & Sullivan (1998) Collins JK Thornton G Sullivan GO Selection of probiotic strains for human applications International Dairy Journal 1998 8 5–6 487 490 10.1016/S0958-6946(98)00073-9 

  23. Delzenne et al. (2011) Delzenne NM Neyrinck AM Bäckhed F Cani PD Targeting gut microbiota in obesity: effects of prebiotics and probiotics Nature Reviews Endocrinology 2011 7 11 639 646 10.1038/nrendo.2011.126 

  24. Drew, Diuxon & Dixon (2007) Drew BS Diuxon AF Dixon JB Obesity management: update on orlistat Vascular Health Risk Management 2007 3 6 817 821 18200802 

  25. Everard et al. (2011) Everard A Lazarevic V Derrien M Girard M Muccioli GG Neyrinck AM Possemiers S Van Holle A François P De Vos WM Delzenne NM Schrenzel J Cani PD Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice Diabetes 2011 60 11 2775 2786 10.2337/db11-0227 21933985 

  26. Furukawa et al. (2017) Furukawa S Fujita T Shimabukuro M Iwaki M Yamada Y Nakajima Y Nakayama O Makishima M Matsuda M Shimomura I Increased oxidative stress in obesity and its impact on metabolic syndrome Journal of Clinical Investigation 2017 114 12 1752 1761 10.1172/JCI200421625 

  27. Gérard (2016) Gérard P Gut microbiota and obesity Cellular and Molecular Life Sciences 2016 73 1 147 162 10.1007/s00018-015-2061-5 26459447 

  28. Gionchetti et al. (2000) Gionchetti P Rizzello F Venturi A Campieri M Probiotics in infective diarrhoea and inflammatory bowel diseases Journal of Gastroenterology and Hepatology 2000 15 5 489 493 10.1046/j.1440-1746.2000.02162.x 10847433 

  29. Greiner & Bäckhed (2011) Greiner T Bäckhed F Effects of the gut microbiota on obesity and glucose homeostasis Trends in Endocrinology and Metabolism 2011 22 4 117 123 10.1016/j.tem.2011.01.002 21353592 

  30. Heck, Yanovski & Calis (2012) Heck AM Yanovski JA Calis KA Orlistat, a new lipase inhibitor for the management of obesity Pharmacotherapy 2012 20 3 270 279 10.1592/phco.20.4.270.34882 

  31. Hemarajata & Versalovic (2013) Hemarajata P Versalovic J Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation Therapeutic Advances in Gastroenterology 2013 6 1 39 51 10.1177/1756283X12459294 23320049 

  32. Hill et al. (2014) Hill C Guarner F Reid G Gibson GR Merenstein DJ Pot B Morelli L Canani RB Flint HJ Salminen S Calder PC Sander ME The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic National Reviews on Gastroenterology & Hepatology 2014 11 8 506 514 10.1038/nrgastro.2014.66 

  33. Inui (2003) Inui A Obesity—a chronic health problem in cloned mice? Trends in Pharmacological Sciences 2003 24 2 77 80 10.1016/S0165-6147(02)00051-2 12559771 

  34. Islam (2016) Islam SU Clinical uses of probiotics Medicine 2016 95 5 e2658 10.1097/MD.0000000000002658 26844491 

  35. Ji et al. (2012) Ji YS Kim HN Park HJ Lee JE Yeo SY Yang JS Park SY Yoon HS Cho GS Franz CM Bomba A Shin HK Holzapfel WH Modulation of the murine microbiome with a concomitant anti-obesity effect by Lactobacillus rhamnosus GG and Lactobacillus sakei NR28 Beneficial Microbes 2012 3 1 13 22 10.3920/BM2011.0046 22348905 

  36. Jia et al. (2008) Jia W Li H Zhao L Nicholson JK Gut microbiota: a potential new territory for drug targeting Nature Reviews Drug Discovery 2008 7 2 123 129 10.1038/nrd2505 18239669 

  37. Kadooka et al. (2010) Kadooka YM Sato M Imaizumi K Ogawa A Ikuyama K Akai Y Okano M Kagoshima M Tsuchida T Regulation of abdominal adiposity by probiotics ( Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial European Journal of Clinical Nutrition 2010 64 6 636 643 10.1038/ejcn.2010.19 20216555 

  38. Karimi et al. (2015) Karimi G Sabran MR Jamaluddin R Parvaneh K Mohtarrudin N Ahmad Z Khazaai H Khodavandi A The anti-obesity effects of Lactobacillus casei strain Shirota versus Orlistat on high fat diet-induced obese rats Food & Nutrition Research 2015 59 1 29273 10.3402/fnr.v59.29273 26699936 

  39. Khan et al. (2014) Khan M Patrick AL Fox-Robichaud AE The Canadian Critical Care Translational Biology Group Development of a murine model of early sepsis in diet-induced obesity BioMed Research International 2014 2014 1 11 10.1155/2014/719853 

  40. Kim et al. (2016) Kim B Park K-Y Ji Y Park S Holzapfel W Hyun C-K Protective effects of Lactobacillus rhamnosus GG against dyslipidemia in high-fat diet-induced obese mice Biochemical and Biophysical Research Communications 2016 473 2 530 536 10.1016/j.bbrc.2016.03.107 27018382 

  41. Kobyliak et al. (2017) Kobyliak N Falalyeyeva T Beregova T Spivak M Probiotics for experimental obesity prevention: focus on strain dependence and viability of composition Endokrynologia Polska 2017 68 6 659 667 10.5603/EP.a2017.0055 29022648 

  42. Kollaritsch et al. (1993) Kollaritsch HH Holst H Grobara P Wiedermann G Prevention of traveler’s diarrhea with Saccharomyces boulardii . Results of a placebo controlled double-blind study Fortschritte der Medizin 1993 111 9 152 156 8486328 

  43. Kollaritsch et al. (1989) Kollaritsch HH Kremsner P Wiedermann G Scheiner O Prevention of traveller’s diarrhea: comparison of different non-antibiotic preparation Travel Medicine International 1989 6 9 17 

  44. Larsen et al. (2006) Larsen CN Nielsen S Kaestel P Brockmann E Bennedsen M Christensen HR Eskesen DC Jacobsen BL Michaelsen KF Dose–response study of probiotic bacteria Bifidobacterium animalis subsp. lactis BB-12 and Lactobacillus paracasei subsp. paracasei CRL-341 in healthy young adults European Journal of Clinical Nutrition 2006 60 11 1284 1293 10.1038/sj.ejcn.1602450 16721394 

  45. Larsen et al. (2013) Larsen N Vogensen FK Gobel RJ Michaelsen KF Forssten SD Lahtinen SJ Jakobsen M Effect of Lactobacillus salivarius Ls-33 on fecal microbiota in obese adolescents Clinical Nutrition 2013 32 6 935 940 10.1016/j.clnu.2013.02.007 23510724 

  46. Le Barz et al. (2015) Le Barz M Anhé FF Varin TV Desjardins Y Levy E Roy D Urdaci MC Marette A Probiotics as complementary treatment for metabolic disorders Diabetes & Metabolism Journal 2015 39 4 291 303 10.4093/dmj.2015.39.4.291 26301190 

  47. Lee (2013) Lee CY The effect of high-fat diet-induced pathophysiological changes in the gut on obesity: what should be the ideal treatment? Clinical and Translational Gastroenterology 2013 4 7 e39 10.1038/ctg.2013.11 23842483 

  48. Ley et al. (2005) Ley RE Bäckhed F Turnbaugh P Lozupone CA Knight RD Gordon JI Obesity alters gut microbial ecology Proceedings of the National Academy of Science of the United States of America 2005 102 31 11070 11075 

  49. Lim et al. (2016) Lim SM Jeong JJ Woo KH Han MJ Kim DH Lactobacillus sakei OK67 ameliorates high-fat diet–induced blood glucose intolerance and obesity in mice by inhibiting gut microbiota lipopolysaccharide production and inducing colon tight junction protein expression Nutrition Research 2016 36 4 337 348 10.1016/j.nutres.2015.12.001 27001279 

  50. Ludwig et al. (2018) Ludwig DS Willett WC Volek JS Neuhouser ML Dietary fact: from foe to friend? Science 2018 362 6416 764 770 10.1126/science.aau2096 30442800 

  51. Ma et al. (2013) Ma Y-Y Li L Yu C-H Shen Z Chen L-H Li Y-M Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis World Journal of Gastroenterology 2013 19 40 6911 6918 10.3748/wjg.v19.i40.6911 24187469 

  52. Ma, Zhou & Li (2017) Ma J Zhou Q Li H Gut Microbiota and nonalcoholic fatty liver disease: insights on mechanisms and therapy Nutrients 2017 9 10 1124 10.3390/nu9101124 

  53. Madsen (2012) Madsen KL Enhancement of epithelial barrier function by probiotics Journal of Epithelial Biology and Pharmacology 2012 5 1 55 59 10.2174/1875044301205010055 

  54. Mekkes et al. (2013) Mekkes MC Weenen TC Brummer RJ Claassen E The development of probiotic treatment in obesity: a review Beneficial Microbes 2013 5 1 19 28 10.3920/BM2012.0069 

  55. Minami et al. (2018) Minami J Iwabuchi N Tanaka M Yamauchi K Xiao J Abe F Sakane N Effects of Bifidobacterium breve B-3 on body fat reductions in pre-obese adults: a randomized, double-blind, placebo-controlled trial Bioscience of Microbiota, Food and Health 2018 37 3 67 75 10.12938/bmfh.18-001 

  56. Minami et al. (2015) Minami J Kondo S Yanagisawa N Odamak T Xiao J Abe F Nakajima S Hamamoto Y Saitoh S Shimoda T Oral administration of Bifidobacterium breve B-3 modifies metabolic functions in adults with obese tendencies in a randomised controlled trial Journal of Nutritional Science 2015 4 1 7 10.1017/jns.2015.5 

  57. Neuhofer et al. (2014) Neuhofer A Wernly B Leitner L Sarai A Sommer NG Staffler G Zeyda M Stulnig TM An accelerated mouse model for atherosclerosis and adipose tissue inflammation Cardiovascular Diabetology 2014 13 1 23 10.1186/1475-2840-13-23 24438079 

  58. Olufadi & Byrne (2008) Olufadi R Byrne CD Clinical and laboratory diagnosis of the metabolic syndrome Journal of Clinical Pathology 2008 61 6 697 706 10.1136/jcp.2007.048363 18505888 

  59. Ouwehand, Salminen & Isolauri (2002) Ouwehand AC Salminen S Isolauri E Probiotics: an overview of beneficial effects Lactic Acid Bacteria: Genetics, Metabolism and Applications 2002 82 279 289 10.1007/978-94-017-2029-8_18 

  60. Paolella et al. (2014) Paolella G Mandato C Pierri L Poeta M Di Stasi M Vajro P Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease World Journal of Gastroenterology 2014 20 42 15518 15531 10.3748/wjg.v20.i42.15518 25400436 

  61. Park et al. (2013) Park DY Ahn YT Park SH Huh CS Yoo SR Yu R Sung MK McGregor RA Choi MS Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in diet-induced obese mice is associated with gut microbial changes and reduction in obesity PLOS ONE 2013 8 3 e59470 10.1371/journal.pone.0059470 23555678 

  62. Park et al. (2016) Park S Ji Y Park H Lee K Park H Beck BR Shin H Holzapfel WH Evaluation of functional properties of lactobacilli isolated from Korean white kimchi Food Control 2016 69 5 12 10.1016/j.foodcont.2016.04.037 

  63. Perdigón, Alvarez & De Ruiz Holgado (1991) Perdigón G Alvarez S De Ruiz Holgado AP Immunoadjuvant activity of oral Lactobacillus casei : influence of dose on the secretory immune response and protective capacity in intestinal infections Journal of Dairy Research 1991 58 4 485 496 10.1017/s0022029900030090 1722492 

  64. Raoult (2009) Raoult D Probiotics and obesity: a link? Nature Reviews Microbiology 2009 7 9 616 10.1038/nrmicro2209 

  65. Reid et al. (2017) Reid G Abrahamsson T Bailey M Bindels LB Bubnov R Ganguli K Martoni C O’Neill C Savignac HM Stanton C Ship N Surette M Tuohy K Van Hemert S How do probiotics and prebiotics function at distant sites? Beneficial Microbes 2017 8 4 521 533 10.3920/BM2016.0222 28726511 

  66. Ritze et al. (2014) Ritze Y Bárdos G Claus A Ehrmann V Bergheim I Schwiertz A Bischoff SC Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice PLOS ONE 2014 9 1 e80169 10.1371/journal.pone.0080169 24475018 

  67. Salminen et al. (1998) Salminen S Von Wright A Morelli L Marteau P Brassart D De Vos WM Fondén R Saxelin M Collins K Mogensen G Demonstration of safety of probiotics—a review International Journal of Food Microbiology 1998 44 1–2 93 106 10.1016/s0168-1605(98)00128-7 9849787 

  68. Schroeder et al. (2018) Schroeder BO Birchenough GMH Stahlman M Arike L Johansson MEV Hansson GC Bäckhed F Bifidobacteria or fiber protects against diet-induced Microbiota-Mediated Colonic Mucus Deterioration Cell Host & Microbe 2018 23 1 27 40e7 10.1016/j.chom.2017.11.004 29276171 

  69. Schwartz et al. (2017) Schwartz MW Seeley TJ Zeltser LM Drewnowski A Ravussin E Redman LM Leibel RL Obesity pathogenesis: an Endocrine Society scientific statement Endocrine Reviews 2017 38 4 267 296 10.1210/er.2017-00111 28898979 

  70. Shavakhi et al. (2013) Shavakhi A Minakari M Firouzian H Assali R Hekmatdoost A Ferns G Effect of a Probiotic and Metformin on Liver Aminotransferases in non-alcoholic Steatohepatitis: a double blind randomized clinical trial International Journal of Preventive Medicine 2013 4 5 531 537 23930163 

  71. Siri-Tarino et al. (2010) Siri-Tarino PW Sun Q Hu FB Krauss RM Saturated fat, carbohydrate, and cardiovascular disease American Journal of Clinical Nutrition 2010 91 3 502 509 10.3945/ajcn.2008.26285 20089734 

  72. Speakman et al. (2007) Speakman J Hambly C Mitchell S Krol E Animal models of obesity Obesity Reviews 2007 8 s1 55 61 10.1111/j.1467-789X.2007.00319.x 17316303 

  73. Steer et al. (2000) Steer TH Carpenter H Tuohy K Gibson GR Perspectives on the role of the human gut microbiota and its modulation by pro- and prebiotics Nutrition Research Reviews 2000 13 2 229 254 10.1079/095442200108729089 19087441 

  74. Tanentsapf, Heitmann & Adegboye (2011) Tanentsapf I Heitmann BL Adegboye ARA Systematic review of clinical trials on dietary interventions to prevent excessive weight gain during pregnancy among normal weight, overweight and obese women BMC Pregnancy and Childbirth 2011 11 1 81 10.1186/1471-2393-11-81 22029725 

  75. Turnbaugh et al. (2008) Turnbaugh PJ Bäckhed F Fulton L Gordon JI Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome Cell Host & Microbe 2008 3 4 213 223 10.1016/j.chom.2008.02.015 18407065 

  76. Turnbaugh et al. (2006) Turnbaugh PJ Ley RE Mahowald MA Magrini V Mardis ER Gordon JI An obesity-associated gut microbiome with increased capacity for energy harvest Nature 2006 444 7122 1027 1031 10.1038/nature05414 17183312 

  77. Vemuri, Gundamaraju & Eri (2017) Vemuri R Gundamaraju R Eri R Role of lactic acid probiotic bacteria in IBD Current Pharmaceutical Design 2017 23 16 2352 2355 10.2174/1381612823666170207100025 28176664 

  78. Wang et al. (2015) Wang J Tang H Zhang C Zhao Y Derrien M Rocher E Van-Hylckama Vlieg JE Strissel K Zhao L Obin M Shen J Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice ISME Journal 2015 9 1 1 15 10.1038/ismej.2014.99 24936764 

  79. WGO (2017) WGO World Gastroenterology Organisation Global Guidelines—Probiotics and prebiotics 2017 http://www.worldgastroenterology.org/UserFiles/file/guidelines/probiotics-and-prebiotics-english-2017.pdf 

  80. Woodard et al. (2009) Woodard GA Encarnacion B Downey JR Peraza J Chong K Hernandez-Boussard T Morton JM Probiotics improve outcomes after Roux-en-Y gastric bypass surgery: a prospective randomized trial Journal of Gastrointestinal Surgery 2009 13 7 1198 1204 10.1007/s11605-009-0891-x 19381735 

  81. Yanovski & Yanovski (2014) Yanovski SZ Yanovski JA Long-term drug treatment for obesity: a systematic and clinical review JAMA 2014 311 1 74 86 10.1001/jama.2013.281361 24231879 

LOADING...

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로